284 related articles for article (PubMed ID: 21543548)
1. Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
Kotz D; Fidler JA; West R
Nicotine Tob Res; 2011 Sep; 13(9):793-9. PubMed ID: 21543548
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
[TBL] [Abstract][Full Text] [Related]
3. Varenicline in the management of smoking cessation: a single technology appraisal.
Hind D; Tappenden P; Peters J; Kenjegalieva K
Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
[TBL] [Abstract][Full Text] [Related]
4. General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.
Johnson M; Anderson P; Lockhart I
BMC Fam Pract; 2014 Mar; 15():47. PubMed ID: 24645823
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
[TBL] [Abstract][Full Text] [Related]
6. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
Etter JF; Schneider NG
Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database.
Kotz D; Simpson C; Viechtbauer W; van Schayck OC; West R; Sheikh A
BMJ Open; 2014 Aug; 4(8):e005281. PubMed ID: 25168037
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
Linden K; Jormanainen V; Linna M; Sintonen H; Wilson K; Kotomäki T
Curr Med Res Opin; 2010 Mar; 26(3):549-60. PubMed ID: 20050814
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis.
Mills EJ; Wu P; Lockhart I; Thorlund K; Puhan M; Ebbert JO
Ann Med; 2012 Sep; 44(6):588-97. PubMed ID: 22860882
[TBL] [Abstract][Full Text] [Related]
10. Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: rationale, methods and participant characteristics of the FLEX trial.
Tulloch H; Pipe A; Els C; Aitken D; Clyde M; Corran B; Reid RD
Contemp Clin Trials; 2014 Jul; 38(2):304-13. PubMed ID: 24861558
[TBL] [Abstract][Full Text] [Related]
11. Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.
Steinberg MB; Bover MT; Richardson DL; Schmelzer AC; Williams JM; Foulds J
Drug Alcohol Depend; 2011 Mar; 114(1):77-81. PubMed ID: 20951511
[TBL] [Abstract][Full Text] [Related]
12. 'Real-world' effectiveness of smoking cessation treatments: a population study.
Kotz D; Brown J; West R
Addiction; 2014 Mar; 109(3):491-9. PubMed ID: 24372901
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with the use of aids to cessation in English smokers.
Kotz D; Fidler J; West R
Addiction; 2009 Aug; 104(8):1403-10. PubMed ID: 19549267
[TBL] [Abstract][Full Text] [Related]
14. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy.
Kralikova E; Kmetova A; Stepankova L; Zvolska K; Davis R; West R
Addiction; 2013 Aug; 108(8):1497-502. PubMed ID: 23668486
[TBL] [Abstract][Full Text] [Related]
15. The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
Szatkowski L; Coleman T; McNeill A; Lewis S
Addiction; 2011 Oct; 106(10):1827-34. PubMed ID: 21561500
[TBL] [Abstract][Full Text] [Related]
16. Prescribing of smoking cessation medication in England since the introduction of varenicline.
Langley TE; Huang Y; McNeill A; Coleman T; Szatkowski L; Lewis S
Addiction; 2011 Jul; 106(7):1319-24. PubMed ID: 21395894
[TBL] [Abstract][Full Text] [Related]
17. Smoking cessation: an overview of treatment options with a focus on varenicline.
Stack NM
Pharmacotherapy; 2007 Nov; 27(11):1550-7. PubMed ID: 17963463
[TBL] [Abstract][Full Text] [Related]
18. Quitting smoking before and after varenicline: a population study based on two representative samples of US smokers.
Zhu SH; Cummins SE; Gamst AC; Wong S; Ikeda T
Tob Control; 2016 Jul; 25(4):464-9. PubMed ID: 26283713
[TBL] [Abstract][Full Text] [Related]
19. Smoking cessation-recent advances.
McNeil JJ; Piccenna L; Ioannides-Demos LL
Cardiovasc Drugs Ther; 2010 Aug; 24(4):359-67. PubMed ID: 20602163
[TBL] [Abstract][Full Text] [Related]
20. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
Lutz MA; Lovato P; Cuesta G
Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
